Showing results (81-90 of 162) with videos related to
Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|April 9, 2014
SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patientsDouglas Dieterich, Tarik Asselah, Dominique Guyader, et al.Journal of Hepatology|December 15, 2010
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisVlad Ratziu, Victor de Ledinghen, Fréderic Oberti, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 17, 2015
The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patientsNatalie Funakoshi, Iphigénie Chaze, Anne-Sophie Alary, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2023
Diagnosis and management of hepatic encephalopathy: The French recommendationsDominique Thabut, Charlotte Bouzbib, Lucy Meunier, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 14, 2021
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)Melina Santos, Camelia Protopopescu, Elizabeth Delarocque-Astagneau, et al.Drug Safety|December 4, 2025
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert ConsensusAnna Fettiplace, Arie Regev, Alexandre Kiazand, et al.Antimicrobial Agents and Chemotherapy|July 17, 2013
Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis CDominique Larrey, Ansgar W Lohse, Christian Trepo, et al.Journal of Virology|October 19, 2007
Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependentSonia Molina, Valerie Castet, Lydiane Pichard-Garcia, et al.Journal of Viral Hepatitis|September 10, 2024
Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)Tangui Barré, Lucia Parlati, Marc Bourlière, et al.European Journal of Clinical Pharmacology|August 11, 2012
Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT)Sinem Ezgi Gulmez, Dominique Larrey, Georges-Philippe Pageaux, et al.Pageof 17